Is Akebia Ther Stock a Good Investment?
Akebia Ther Investment Advice | AKBA |
- Examine Akebia Ther's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Akebia Ther's leadership team and their track record. Good management can help Akebia Ther navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Akebia Ther's business and its evolving consumer preferences.
- Compare Akebia Ther's performance and market position to its competitors. Analyze how Akebia Ther is positioned in terms of product offerings, innovation, and market share.
- Check if Akebia Ther pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Akebia Ther's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Akebia Ther stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Akebia Ther is a good investment.
Sell | Buy |
Strong Hold
Market Performance | Good | Details | |
Volatility | Very risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Akebia Ther Stock
Researching Akebia Ther's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 27.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.22. Akebia Ther had not issued any dividends in recent years.
To determine if Akebia Ther is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Akebia Ther's research are outlined below:
| Akebia Ther appears to be risky and price may revert if volatility continues | |
| Akebia Ther has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 194.62 M. Net Loss for the year was (51.92 M) with profit before overhead, payroll, taxes, and interest of 140.04 M. | |
| Akebia Ther currently holds about 143.89 M in cash with (23.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.78. | |
| Akebia Ther has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference |
Akebia Ther Quarterly Liabilities And Stockholders Equity |
|
Akebia Ther uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Akebia Ther. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Akebia Ther's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Akebia Ther's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Akebia Ther's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-08 | 2024-06-30 | -0.05 | -0.04 | 0.01 | 20 | ||
2024-05-09 | 2024-03-31 | -0.08 | -0.09 | -0.01 | 12 | ||
2024-11-06 | 2024-09-30 | -0.06 | -0.1 | -0.04 | 66 | ||
2023-08-25 | 2023-06-30 | -0.02 | -0.06 | -0.04 | 200 | ||
2024-03-14 | 2023-12-31 | -0.04 | 0.0032 | 0.0432 | 108 | ||
2022-05-09 | 2022-03-31 | -0.29 | -0.35 | -0.06 | 20 | ||
2020-08-10 | 2020-06-30 | -0.5 | -0.44 | 0.06 | 12 | ||
2022-03-01 | 2021-12-31 | -0.33 | -0.4 | -0.07 | 21 |
Know Akebia Ther's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Akebia Ther is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Akebia Ther backward and forwards among themselves. Akebia Ther's institutional investor refers to the entity that pools money to purchase Akebia Ther's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Federated Hermes Inc | 2024-09-30 | 868 K | Fmr Inc | 2024-09-30 | 682 K | Bank Of New York Mellon Corp | 2024-06-30 | 604.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 568.7 K | Nuveen Asset Management, Llc | 2024-06-30 | 380.5 K | Goldman Sachs Group Inc | 2024-06-30 | 348.9 K | Susquehanna International Group, Llp | 2024-06-30 | 248.8 K | Marshall Wace Asset Management Ltd | 2024-06-30 | 247.1 K | Rhumbline Advisers | 2024-06-30 | 247.1 K | Blackrock Inc | 2024-06-30 | 11.6 M | Vanguard Group Inc | 2024-09-30 | 10.1 M |
Akebia Ther's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 449.45 M.Market Cap |
|
Akebia Ther's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.35) | (0.37) | |
| Return On Capital Employed | (0.33) | (0.34) | |
| Return On Assets | (0.21) | (0.23) | |
| Return On Equity | 1.70 | 1.78 |
Determining Akebia Ther's profitability involves analyzing its financial statements and using various financial metrics to determine if Akebia Ther is a good buy. For example, gross profit margin measures Akebia Ther's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Akebia Ther's profitability and make more informed investment decisions.
Please note, the presentation of Akebia Ther's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Akebia Ther's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Akebia Ther's management manipulating its earnings.
Evaluate Akebia Ther's management efficiency
Akebia Ther has return on total asset (ROA) of (0.0937) % which means that it has lost $0.0937 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.5345) %, meaning that it created substantial loss on money invested by shareholders. Akebia Ther's management efficiency ratios could be used to measure how well Akebia Ther manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 1.78, whereas Return On Tangible Assets are forecasted to decline to (0.37). At present, Akebia Ther's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 182 M, whereas Other Current Assets are forecasted to decline to about 12.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.16) | (0.15) | |
| Tangible Book Value Per Share | (0.67) | (0.64) | |
| Enterprise Value Over EBITDA | (42.77) | (40.63) | |
| Price Book Value Ratio | (7.60) | (7.22) | |
| Enterprise Value Multiple | (42.77) | (40.63) | |
| Price Fair Value | (7.60) | (7.22) | |
| Enterprise Value | 293.7 M | 394.5 M |
Akebia Ther's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Beta 0.734 |
Basic technical analysis of Akebia Stock
As of the 1st of December, Akebia Ther shows the risk adjusted performance of 0.1104, and Mean Deviation of 2.57. Akebia Ther technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Akebia Ther's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Akebia Ther insiders, such as employees or executives, is commonly permitted as long as it does not rely on Akebia Ther's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Akebia Ther insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Akebia Ther's Outstanding Corporate Bonds
Akebia Ther issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Akebia Ther uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Akebia bonds can be classified according to their maturity, which is the date when Akebia Ther has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Understand Akebia Ther's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Akebia Ther's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1104 | |||
| Market Risk Adjusted Performance | 0.2933 | |||
| Mean Deviation | 2.57 | |||
| Semi Deviation | 2.57 | |||
| Downside Deviation | 3.15 | |||
| Coefficient Of Variation | 746.53 | |||
| Standard Deviation | 3.91 | |||
| Variance | 15.28 | |||
| Information Ratio | 0.0987 | |||
| Jensen Alpha | 0.2823 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.1227 | |||
| Treynor Ratio | 0.2833 | |||
| Maximum Drawdown | 26.21 | |||
| Value At Risk | (4.11) | |||
| Potential Upside | 6.22 | |||
| Downside Variance | 9.9 | |||
| Semi Variance | 6.62 | |||
| Expected Short fall | (3.35) | |||
| Skewness | 1.82 | |||
| Kurtosis | 8.44 |
| Risk Adjusted Performance | 0.1104 | |||
| Market Risk Adjusted Performance | 0.2933 | |||
| Mean Deviation | 2.57 | |||
| Semi Deviation | 2.57 | |||
| Downside Deviation | 3.15 | |||
| Coefficient Of Variation | 746.53 | |||
| Standard Deviation | 3.91 | |||
| Variance | 15.28 | |||
| Information Ratio | 0.0987 | |||
| Jensen Alpha | 0.2823 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.1227 | |||
| Treynor Ratio | 0.2833 | |||
| Maximum Drawdown | 26.21 | |||
| Value At Risk | (4.11) | |||
| Potential Upside | 6.22 | |||
| Downside Variance | 9.9 | |||
| Semi Variance | 6.62 | |||
| Expected Short fall | (3.35) | |||
| Skewness | 1.82 | |||
| Kurtosis | 8.44 |
Consider Akebia Ther's intraday indicators
Akebia Ther intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Akebia Ther stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Akebia Ther Corporate Filings
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 3rd of September 2024 Other Reports | ViewVerify | |
F4 | 2nd of July 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Akebia Stock media impact
Far too much social signal, news, headlines, and media speculation about Akebia Ther that are available to investors today. That information is available publicly through Akebia media outlets and privately through word of mouth or via Akebia internal channels. However, regardless of the origin, that massive amount of Akebia data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Akebia Ther news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Akebia Ther relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Akebia Ther's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Akebia Ther alpha.
Akebia Ther Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Akebia Ther can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Akebia Ther Corporate Management
| Nicole Hadas | Sr. VP, General Counsel and Secretary | Profile | |
| Kristie Bolieau | VP Controller | Profile | |
| Mercedes Carrasco | Director Communications | Profile | |
| David Spellman | CFO VP | Profile | |
| Tracey Vetterick | Vice Administration | Profile | |
| Thierry Bilbault | VP Devel | Profile |
Already Invested in Akebia Ther?
The danger of trading Akebia Ther is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Akebia Ther is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Akebia Ther. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Akebia Ther is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Akebia Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akebia Ther's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akebia Ther Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akebia Ther Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akebia Ther. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akebia Ther. If investors know Akebia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akebia Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.22) | Revenue Per Share 0.834 | Quarterly Revenue Growth (0.11) | Return On Assets (0.09) | Return On Equity (5.53) |
The market value of Akebia Ther is measured differently than its book value, which is the value of Akebia that is recorded on the company's balance sheet. Investors also form their own opinion of Akebia Ther's value that differs from its market value or its book value, called intrinsic value, which is Akebia Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akebia Ther's market value can be influenced by many factors that don't directly affect Akebia Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Akebia Ther's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Akebia Ther is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akebia Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.